2022

1. Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for "diabesity"

   Journal of Medicinal Chemistry, Vol. 65, Núm. 7, pp. 5449-5461